The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Chemokine (C-C Motif) Ligand 2 Engages CCR2+ Stromal Cells of Monocytic Origin to Promote Breast Cancer Metastasis to Lung and Bone
Open accessAbstract
Metastatic spread of cancer to distant vital organs, including lung and bone, is the overwhelming cause of breast cancer mortality and morbidity. Effective treatment of systemic metastasis relies on the identification and functional characterization of metastasis mediators to multiple organs. Overexpression of the chemokine (C-C motif) ligand 2 (CCL2) is frequently associated with advanced tumor stage and metastatic relapse in breast cancer. However, the functional mechanism of CCL2 in promoting organ-specific metastasis of breast cancer has not been rigorously investigated. Here, we used organ-specific metastatic sublines of the MDA-MB-231 human breast cancer cell line to demonstrate that overexpression of CCL2 promotes breast cancer metastasis to both lung and bone. Conversely, blocking CCL2 function with a neutralizing antibody reduced lung and bone metastases. The enhancement of lung and bone metastases by CCL2 was associated with increased macrophage infiltration and osteoclast differentiation, respectively. By performing functional assays with primary cells isolated from the wild type, CCL2 and CCR2 knock-out mice, we showed that tumor cell-derived CCL2 depends on its receptor CCR2 (chemokine, CC motif, receptor 2) expressed on stromal cells to exert its function in promoting macrophage recruitment and osteoclast differentiation. Overall, these data demonstrated that CCL2-expressing breast tumor cells engage CCR2(+) stromal cells of monocytic origin, including macrophages and preosteoclasts, to facilitate colonization in lung and bone. Therefore, CCL2 and CCR2 are promising therapeutic targets for simultaneously inhibiting lung and bone metastasis of breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
Metastasis to bone: causes, consequences and therapeutic opportunities
Mundy, G. R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc867 · Cited by 2,777
Roodman, G. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030831 · Cited by 2,755
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
Self-citationCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Genes that mediate breast cancer metastasis to the brain
Bos, P. D., Zhang, X. H.-F., Nadal, C., Shu, W., Gomis, R. R., Nguyen, D. X., Minn, A. J., van de Vijver, M. J., Gerald, W. L., Foekens, J. A., et al. (2009) · Nature · doi:10.1038/nature08021 · Cited by 1,863
F4/80, a monoclonal antibody directed specifically against the mouse macrophage
Austyn, J. M., & Gordon, S. (1981) · European Journal of Immunology · doi:10.1002/eji.1830111013 · Cited by 1,579
Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.
Leek, R., Lewis, C. E., Whitehouse, R. M., Greenall, M. J., Clarke, J., & Harris, A. L. (1996) · PubMed · Cited by 1,187
Tsou, C.-L., Peters, W., Si, Y., Slaymaker, S., Aslanian, A. M., Weisberg, S. P., Mack, M., & Charo, I. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29919 · Cited by 1,152
Boring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Broxmeyer, H. E., & Charo, I. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119798 · Cited by 1,096
Macrophages and Polymorphonuclear Neutrophils in Lung Defense and Injury
Sibille, Y., & Reynolds, H. Y. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.2.471 · Cited by 1,083
Wiktor-Jedrzejczak, W., Bartocci, A., Ferrante, A. W., Ahmed-Ansari, A., Sell, K. W., Pollard, J. W., & Stanley, E. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4828 · Cited by 1,031
Lu, B., Rutledge, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R., Gerard, C., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017
Salcedo, R., Ponce, M. L., Young, H. A., Wasserman, K., Ward, J. M., Kleinman, H. K., Oppenheim, J. J., & Murphy, W. J. (2000) · Blood · doi:10.1182/blood.v96.1.34 · Cited by 859
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors
Minn, A. J., Kang, Y., Serganova, I. S., Gupta, G. P., Giri, D. D., Doubrovin, M., Ponomarev, V., Gerald, W. L., Blasberg, R. G., & Massagué, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522320 · Cited by 742
Self-citation(2000) · PubMed · Cited by 706
Charo, I. F., Myers, S. J., Herman, A., Franci, C., Connolly, A. J., & Coughlin, S. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2752 · Cited by 705
CA A Cancer Journal for Clinicians
(2008) · CA A Cancer Journal for Clinicians · doi:10.1002/(issn)1542-4863 · Cited by 636
Huang, D., Wang, J., Kivisakk, P., Rollins, B. J., & Ransohoff, R. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.713 · Cited by 583
Osteopetrosis in mice lacking haematopoietic transcription factor PU.1
Tondravi, M. M., McKercher, S. R., Anderson, K., Erdmann, J. M., Quiroz, M., Maki, R., & Teitelbaum, S. L. (1997) · Nature · doi:10.1038/386081a0 · Cited by 539
Boucharaba, A., Serre, C.-M., Grès, S., Saulnier-Blache, J. S., Bordet, J.-C., Guglielmi, J., Clézardin, P., & Peyruchaud, O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422123 · Cited by 462
Dwyer, R. M., Potter-Beirne, S. M., Harrington, K. A., Lowery, A. J., Hennessy, E., Murphy, J. M., Barry, F. P., O'Brien, T., & Kerin, M. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0731 · Cited by 431
Markers of mouse macrophage development detected by monoclonal antibodies
Leenen, P. J. M., de Bruijn, M. F. T. R., Voerman, J. S. A., Campbell, P. A., & van Ewijk, W. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90005-1 · Cited by 333
Loberg, R. D., Ying, C., Craig, M., Day, L. L., Sargent, E., Neeley, C., Wojno, K., Snyder, L. A., Yan, L., & Pienta, K. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1286 · Cited by 333
Aubin, J. E., & Bonnelye, E. (2000) · Osteoporosis International · doi:10.1007/s001980070028 · Cited by 319
CCL2 (monocyte chemoattractant protein-1) and cancer
Conti, I., & Rollins, B. J. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.009 · Cited by 314
Lu, X., Wang, Q., Hu, G., Van Poznak, C., Fleisher, M., Reiss, M., Massagué, J., & Kang, Y. (2009) · Genes & Development · doi:10.1101/gad.1824809 · Cited by 304
Self-citationSaji, H., Koike, M., Yamori, T., Saji, S., Seiki, M., Matsushima, K., & Toi, M. (2001) · Cancer · doi:10.1002/1097-0142(20010901)92:5<1085::aid-cncr1424>3.0.co;2-k · Cited by 288
Monocyte chemoattractant protein-1: A key mediator in inflammatory processes
Melgarejo, E., Medina, M. Á., Sánchez-Jiménez, F., & Urdiales, J. L. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.07.018 · Cited by 283
A Key Role for Cc Chemokine Receptor 4 in Lipopolysaccharide-Induced Endotoxic Shock
Chvatchko, Y., Hoogewerf, A. J., Meyer, A., Alouani, S., Juillard, P., Buser, R., Conquet, F., Proudfoot, A. E. I., Wells, T. N. C., & Power, C. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.10.1755 · Cited by 271
Fujimoto, H., Sangai, T., Ishii, G., Ikehara, A., Nagashima, T., Miyazaki, M., & Ochiai, A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24378 · Cited by 263
Power, C. A., Meyer, A., Nemeth, K., Bacon, K. B., Hoogewerf, A. J., Proudfoot, A. E. I., & Wells, T. N. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.33.19495 · Cited by 262
Organotropism of Breast Cancer Metastasis
Lu, X., & Kang, Y. (2007) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-007-9047-3 · Cited by 259
Self-citationKim, M. S., Day, C. J., & Morrison, N. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412713200 · Cited by 251
Lu, Y., Cai, Z., Galson, D. L., Xiao, G., Liu, Y., George, D. E., Melhem, M. F., Yao, Z., & Zhang, J. (2006) · The Prostate · doi:10.1002/pros.20464 · Cited by 242
Li, X., Qin, L., Bergenstock, M., Bevelock, L. M., Novack, D. V., & Partridge, N. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611781200 · Cited by 229
Kos, C. H., Karaplis, A. C., Peng, J.-B., Hediger, M. A., Goltzman, D., Mohammad, K. S., Guise, T. A., & Pollak, M. R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17416 · Cited by 209
Inflammatory chemokines in cancer growth and progression
Rollins, B. J. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.002 · Cited by 195
Molecular Mechanisms of Breast Cancer Metastases to Bone
Guise, T. A., Kozlow, W. M., Heras-Herzig, A., Padalecki, S. S., Yin, J. J., & Chirgwin, J. M. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.s.004 · Cited by 167
Monocyte Chemotactic Protein-1 Mediates Prostate Cancer–Induced Bone Resorption
Lu, Y., Cai, Z., Xiao, G., Keller, E. T., Mizokami, A., Yao, Z., Roodman, G. D., & Zhang, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1210 · Cited by 162
A Destructive Cascade Mediated by CCL2 Facilitates Prostate Cancer Growth in Bone
Li, X., Loberg, R. D., Liao, J., Chi, Y., Snyder, L. A., Pienta, K. J., & McCauley, L. K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2164 · Cited by 153
Chemokine Networks and Breast Cancer Metastasis
Karnoub, A. E., & Weinberg, R. A. (2007) · Breast Disease · doi:10.3233/bd-2007-26107 · Cited by 136
Monocyte Chemoattractant Protein-1 Serum Levels in Patients with Breast Cancer
Lebrecht, A., Grimm, C., Lantzsch, T., Ludwig, E., Hefler, L., Ulbrich, E. J., & Koelbl, H. (2004) · Tumor Biology · doi:10.1159/000077718 · Cited by 131
Kuroda, T., Kitadai, Y., Tanaka, S., Yang, X., Mukaida, N., Yoshihara, M., & Chayama, K. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0798 · Cited by 129
Lü, X., & Kang, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900108106 · Cited by 120
Self-citationZhu, J., Jia, X., Xiao, G., Kang, Y., Partridge, N. C., & Qin, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705064200 · Cited by 109
Self-citationNam, J., Kang, M., Suchar, A. M., Shimamura, T., Kohn, E. A., Michalowska, A. M., Jordan, V. C., Hirohashi, S., & Wakefield, L. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0825 · Cited by 108
Metastatic breast cancer induces an osteoblast inflammatory response
Kinder, M., Chislock, E. M., Bussard, K. M., Shuman, L. A., & Mastro, A. M. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.09.021 · Cited by 102
Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone
Lü, Y., Chen, Q., Corey, E., Xie, W., Fan, J., Mizokami, A., & Zhang, J. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9226-7 · Cited by 102
Transactivation of MCP‐1/CCL2 by β‐catenin/TCF‐4 in human breast cancer cells
Mestdagt, M., Polette, M., Butticè, G., Noël, A., Ueda, A., Foidart, J., & Gilles, C. (2005) · International Journal of Cancer · doi:10.1002/ijc.21291 · Cited by 85
Monocyte Chemotactic Protein 1 Promotes Lung Cancer–Induced Bone Resorptive Lesions In Vivo
Cai, Z. Y., Chen, Q., Chen, J., Lü, Y., Xiao, G., Wu, Z., Zhou, Q., & Zhang, J. (2009) · Neoplasia · doi:10.1593/neo.81282 · Cited by 78
Lü, Y., Xiao, G., Galson, D. L., Nishio, Y., Mizokami, A., Keller, E. T., Yao, Z., & Zhang, J. (2007) · International Journal of Cancer · doi:10.1002/ijc.22704 · Cited by 65
The clinical course of lung metastases from breast cancer
Schlappack, O. K., Baur, M., Steger, G. G., et al. (1988) · Journal of Molecular Medicine · doi:10.1007/bf01726581 · Cited by 33
Clinicopathologic analysis of macrophage infiltrates in breast carcinoma
Visscher, D. W., Tabaczka, P. M., Long, D., & Crissman, J. D. (1995) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)80658-8 · Cited by 18
Research works printed but not linked: 3
- Ueno, 2000, Clin. Cancer Res., 6, 3282
- Leek, 1996, Cancer Res., 56, 4625
- Minn, 2005, J. Clin. Invest., 115, 44, 10.1172/JCI22320 · doi:10.1172/jci22320 · Paper page
Cited by
Tumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,033
Roles of the immune system in cancer: From tumor initiation to metastatic progression
Gonzalez, H., Hagerling, C., & Werb, Z. (2018) · Genes & Development · doi:10.1101/gad.314617.118 · Cited by 2,111
Pre-metastatic niches: organ-specific homes for metastases
Peinado, H., Zhang, H., Matei, I. R., Costa-Silva, B., Hoshino, A., Rodrigues, G., Psaila, B., Kaplan, R. N., Bromberg, J. F., Kang, Y., et al. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.6 · Cited by 1,889
Self-citationMetastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
Liang, Y., Zhang, H., Song, X., & Yang, Q. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.012 · Cited by 992
Targeting tumor-associated macrophages in cancer
Pathria, P., Louis, T. L., & Varner, J. A. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.02.003 · Cited by 933
Metadata
- Authors
- Lu, X., & Kang, Y.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2009-10
- Volume
- 284
- Issue
- 42
- Pages
- 29087-29096
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1979935206
- Cited by
- 257
- References
- 58
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 3990 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.